Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of Martin Crosby
 

Martin Crosby

 
Founder, Vice Chmn., Acting CEO, Chief Science Officer - Zestra Laboratories Inc.
 
Martin Crosby Email :
Please login
 
Company Name : Zestra Laboratories Inc.
 
Company Website : www.zestra.com
 
Company Address : 4055 Faber Pl. Dr.
Ste. 105, Charleston, SC,
United States,
 
Martin Crosby Profile :
Founder, Vice Chmn., Acting CEO, Chief Science Officer - Zestra Laboratories Inc.
 
Martin Crosby Biography :

Martin Crosby is the founder, Chief Science Officer, and Acting CEO of Zestra Laboratories, Inc., a Delaware Corporation. Crosby is the inventor and developer of Zestra (U.S. Patent 6,737,084 issued May 18th, 2004 and EU Patent EP1328281) with patent rights assigned to Zestra Laboratories, Inc. In 1993, Crosby founded Pharmaceutical Marketing Alliance (PMA), a nationwide pharmaceutical healthcare provider specializing in the disease management of Multiple Sclerosis (MS) patients receiving newly approved drugs for this neurologic condition. PMA was acquired by a publicly traded national healthcare provider specializing in chronic disease state management (Health Management, Inc.) This parent company of PMA was later acquired by Bergen Brunswig Corporation, now Amerisource Bergen (NYSE: ABC). In 1988, Crosby was the lead co-founder of I.V. Therapy Associates (IVT) and served as Senior Vice President. In January 1991, IVT was acquired by Roberts Pharmaceutical Corporation (AMEX: RPC), which later merged with Shire Pharmaceuticals of London (NASDAQ: SHPGY). From 1985-1987 Crosby established, managed and served as the Director of Pharmacy Services for Charleston Home Therapeutics, Inc. This high-tech pharmacy provided home healthcare patients with intravenous therapy services including intravenous antibiotics, TPN, and intravenous pain management to cancer patients. In the 1980s, Crosby initiated an extensive research effort related to the neurochemistry, neuropharmacology and neurophysiology of pain transmission and the critical involvement of serotonin. Crosby s work with neuropharmacologic pain management culminated in the development and patenting of a serotonergic combination product used to control severe intractable chronic pain in terminal cancer patients that had developed tolerance to narcotics. Crosby was granted United States and Canadian patents surrounding this product (U.S. Patent #4,698,342 and U.S. Patent # 4,596,807). Crosby received his B.S. Degree in Pharmacy from the Medical University of South Carolina in 1980.

 
Martin Crosby Colleagues :
Name Title Email

Richard Corlin

Chmn. Please login

Mary Jaensch

Co - Founder, Board Dir., CEO Please login

Rachel Scherl

Co - Founder, Board Dir., Pres. Please login

Adele Oliva

Board Dir. Please login

Lucinda Holt

Board Dir. Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.